PA
Perceptive Advisors Portfolio holdings
AUM
$2.67B
This Quarter Return
+30.71%
1 Year Return
+73.17%
3 Year Return
+837.18%
5 Year Return
+928.4%
10 Year Return
+11,818.45%
AUM
$4.66B
AUM Growth
+$4.66B
(+12%)
Cap. Flow
-$219M
Cap. Flow
% of AUM
-4.69%
Top 10 Holdings %
Top 10 Hldgs %
46.73%
Holding
123
New
13
Increased
23
Reduced
25
Closed
18
Top Buys
| 1 |
VRNA
Verona Pharma
VRNA
|
$112M |
| 2 |
Viking Therapeutics
VKTX
|
$62M |
| 3 |
argenx
ARGX
|
$56M |
| 4 |
Nuvalent
NUVL
|
$44M |
| 5 |
CNTA
Centessa Pharmaceuticals
CNTA
|
$37.6M |
Top Sells
| 1 |
CERE
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
|
$441M |
| 2 |
Madrigal Pharmaceuticals
MDGL
|
$74.1M |
| 3 |
Neurocrine Biosciences
NBIX
|
$50.4M |
| 4 |
Natera
NTRA
|
$39.4M |
| 5 |
Crinetics Pharmaceuticals
CRNX
|
$38.4M |
Sector Composition
| 1 | Healthcare | 100% |
